Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.
about
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesionsMajor clinical research advances in gynecologic cancer in 2013Quantifying mRNA and microRNA with qPCR in cervical carcinogenesis: a validation of reference genes to ensure accurate dataSemantic focusing allows fully automated single-layer slide scanning of cervical cytology slidesCharacterization of topoisomerase II α and minichromosome maintenance protein 2 expression in anal carcinomaProspects for prevention of HPV-driven oropharynx cancer.Evaluation of clinical performance of a novel urine-based HPV detection assay among women attending a colposcopy clinicComputerized delineation of nuclei in liquid-based pap smears stained with immunohistochemical biomarkers.The role of co-factors in the progression from human papillomavirus infection to cervical cancerTriage of HPV-positive women in cervical cancer screening.A promising DNA methylation signature for the triage of high-risk human papillomavirus DNA-positive womenClinical Implication of p16, Ki-67, and Proliferating Cell Nuclear Antigen Expression in Cervical Neoplasia: Improvement of Diagnostic Accuracy for High-grade Squamous Intraepithelial Lesion and Prediction of Resection Margin Involvement on ConizatiThe Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL.Design of a Novel Low Cost Point of Care Tampon (POCkeT) Colposcope for Use in Resource Limited Settings.Predictive value of p16/Ki-67 immunocytochemistry for triage of women with abnormal Papanicolaou test in cervical cancer screening: a systematic review and meta-analysis.Keratoacanthoma of the Lip: Activation of the mTOR Pathway, Tumor Suppressor Proteins, and Tumor Senescencep16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive WomenHuman Papillomavirus Laboratory Testing: the Changing ParadigmTriage of HPV positive women in cervical cancer screening.Triage of ASC-H: A meta-analysis of the accuracy of high-risk HPV testing and other markers to detect cervical precancerMakorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology.Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study.Chromosomal gains measured in cytology samples from women with abnormal cervical cancer screening results.Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinicFrequency of Chlamydia trachomatis infection in cervical intraepithelial lesions and the status of cytological p16/Ki-67 dual-staining.BMVC test, an improved fluorescence assay for detection of malignant pleural effusionsTriaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome studyp16/Ki-67 co-expression associates high risk human papillomavirus persistence and cervical histopathology: a 3-year cohort study in China.Cervical cancer screening: on the way to a shift from cytology to full molecular screening.The clinical impact of using p16(INK4a) immunochemistry in cervical histopathology and cytology: an update of recent developments.Use of artemisinin and its derivatives to treat HPV-infected/transformed cells and cervical cancer: a review.A systematic review of p16/Ki-67 immuno-testing for triage of low grade cervical cytology.FHACT: the FISH-based HPV-associated cancer test that detects nonrandom gain at four genomic loci as biomarkers of disease progression.The Value of a Novel Panel of Cervical Cancer Biomarkers for Triage of HPV Positive Patients and for Detecting Disease Progression.Management of high-risk HPV-positive women for detection of cervical (pre)cancer.[Indications for p16/Ki-67 in cervical cytology].Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.[Categorization of uterine cervix tumors : What's new in the 2014 WHO classification].Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN.
P2860
Q24198236-7971131F-86C4-4ABA-941D-6D7C68C54F11Q24562146-6334CE1F-43D0-48FC-A629-8A0EF1B2F8A8Q30866975-D4C4BF90-92F5-4EBC-996D-4E2632989013Q31115232-4F7EE595-452B-467F-BE74-15D523E2E30CQ33597938-63BE9EB7-C4C5-419E-9FC9-C4F6202436B3Q33759930-E339CF2A-318E-4A23-A444-96B040E5213CQ34097009-9A61B07C-F162-4F0E-8C5A-7A56FB35DD9EQ34301277-8196DCA9-137A-44B3-95D6-66BD6B59A6E3Q34311313-3CBD875C-BFDB-441B-969F-319F8CF2F4B5Q34344762-54734CBF-3F9C-4844-843D-7EA30478269EQ35125113-984C9EF0-88D8-4AB0-8C8B-BEAC9B01B7E8Q35261428-11C3B7E0-95E9-4D11-AC51-FA25684F4C13Q35729645-DB0CE18F-7B1A-4E59-A4F7-5CBF0745763AQ35762447-800E0E44-1CB5-4C08-A70B-8180B0766F27Q36091529-A31EAA2A-286E-4B98-B516-C08ABA85B35AQ36255926-B7284CF9-33EA-46BA-8654-DCF898198E3AQ36361863-CB0F6B01-1C92-4581-9995-AA33B761B129Q36675236-673419E2-0B33-4E24-96A2-F7AEF6326036Q36679896-9589DA35-A59D-4479-AD64-F7ABDAC77B6DQ36803663-01B84E0E-2BEC-4798-9D0D-7C1EBB03FB27Q37204870-F69CDFA4-EE19-42DB-BF6E-0BD2374CE6ECQ37225246-66CB7191-AD09-48EE-97CC-64A32465A357Q37271280-6C51024A-DD0D-4B4F-B21E-AC55A0713F6AQ37324864-0F74F7C2-9083-4B6C-9577-7FC94ECC6CC2Q37546810-197286B2-1785-42EC-8A08-6EBBF7A9817DQ37569565-413C569D-A994-4B09-AAF7-D6F70B23BD91Q37595275-ED6882EE-EFDE-475A-A537-BB118F42815AQ37650670-9D9A9A12-FA76-4345-82B7-28F22DC7DCA7Q37662140-568F2B18-E63A-40D1-B3B3-A88F5475A6E7Q38180277-D4B36ABB-482F-4D65-A8FA-C590FD59C248Q38205174-9933EF08-9213-4AA5-9958-0668A2BF5F30Q38206277-E94731AA-6C04-441C-B12D-A6EFD8E10374Q38248178-B609C546-EB00-49A6-AFC3-0636B1C65BFEQ38259453-EF2EE6C3-D83A-4676-B724-4AF8DEEEDE24Q38753469-5B36974D-CF1B-4CF0-8EAE-5A408BC52C5EQ38837737-161CFBAB-0212-4B16-BEBC-794449DF88CEQ40373166-E6A5C0CB-1CB2-4C75-8580-D838C2255639Q40423402-BE231C5A-80C4-46F8-80FA-F19B21CDAC08Q40483237-528F5E49-7760-40CA-9EB8-3CF9C0A9783FQ40525853-3C502972-1F0E-43EE-81DA-B84BE840BB3F
P2860
Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Performance of p16/Ki-67 immun ...... olposcopy referral population.
@ast
Performance of p16/Ki-67 immun ...... olposcopy referral population.
@en
Performance of p16/Ki-67 immun ...... olposcopy referral population.
@nl
type
label
Performance of p16/Ki-67 immun ...... olposcopy referral population.
@ast
Performance of p16/Ki-67 immun ...... olposcopy referral population.
@en
Performance of p16/Ki-67 immun ...... olposcopy referral population.
@nl
prefLabel
Performance of p16/Ki-67 immun ...... olposcopy referral population.
@ast
Performance of p16/Ki-67 immun ...... olposcopy referral population.
@en
Performance of p16/Ki-67 immun ...... olposcopy referral population.
@nl
P2093
P2860
P50
P1476
Performance of p16/Ki-67 immun ...... olposcopy referral population.
@en
P2093
Joan L Walker
Katie Smith
Lauren Schwartz
Michael A Gold
R Andy Allen
Rosemary E Zuna
S Terence Dunn
P2860
P304
P356
10.1158/1078-0432.CCR-12-0270
P407
P577
2012-06-06T00:00:00Z